StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial
about
The Burn Wound MicroenvironmentAdvances in Skin Substitutes-Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic HealingAdvances in Skin Regeneration Using Tissue EngineeringPrevention of esophageal strictures after endoscopic submucosal dissectionNonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds.A Bioengineered Human Skin Tissue for the Treatment of Infected Wounds.Clinical Evaluation of NIKS-Based Bioengineered Skin Substitute Tissue in Complex Skin Defects: Phase I/IIa Clinical Trial Results.Chimeric Human Skin Substitute Tissue: A Novel Treatment Option for the Delivery of Autologous Keratinocytes.Combinatorial biomatrix/cell-based therapies for restoration of host tissue architecture and function.Engineering the extracellular matrix for clinical applications: endoderm, mesoderm, and ectoderm.Skin substitutes: an overview of the key players in wound management.Randomized, Paired-Site Comparison of Autologous Engineered Skin Substitutes and Split-Thickness Skin Graft for Closure of Extensive, Full-Thickness Burns.Engineered Epidermal Progenitor Cells Can Correct Diet-Induced Obesity and Diabetes.Biomask for skin regeneration.Tissue engineering of skin and regenerative medicine for wound careEngineering Complex Tissues
P2860
Q26753839-BCF43298-D4C1-4C1F-A4D3-68F1A9D1C6D7Q26799872-77A8F454-8345-4107-B773-9CF683EE2B9BQ33624600-BE156588-0AB0-47AF-BCDA-1A70EDCEA010Q34467151-CC2D0F1A-4D21-4BAB-90FD-0FD02218AD7CQ35950558-C8841FA3-FA48-4445-86C2-5F77FC11213DQ36758284-94EE782A-9A59-4350-B9D5-B6BA4D3FCF70Q36758303-31D2944A-4448-4DBD-A027-9778944EB4E5Q37338927-EEBBB3ED-A827-4B56-8B3F-ACF8013AE2FFQ37496432-24B2D789-4D6F-4F26-BE1C-A9BEA81D8C00Q38175899-DCE214A8-3811-4E2E-BDB3-A23D53A25BC4Q38265174-685A5B3A-F065-4D71-9D93-B909B37F5C18Q39610340-72C66B94-9E7A-4516-9DCA-93B9445E96F8Q45870446-84CCE93B-20D1-4B02-A7A7-C9B5A95C1728Q53524025-EE633DD1-62A2-448A-BC9D-A4D91EBFD1ACQ56587028-9DBF7369-82EB-4DAA-AF37-1A423F127276Q57395890-97787AA8-AE88-41FE-839D-B82083A54673
P2860
StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
StrataGraft skin substitute is ...... ntrolled dose escalation trial
@ast
StrataGraft skin substitute is ...... ntrolled dose escalation trial
@en
type
label
StrataGraft skin substitute is ...... ntrolled dose escalation trial
@ast
StrataGraft skin substitute is ...... ntrolled dose escalation trial
@en
prefLabel
StrataGraft skin substitute is ...... ntrolled dose escalation trial
@ast
StrataGraft skin substitute is ...... ntrolled dose escalation trial
@en
P2093
P2860
P1433
P1476
StrataGraft skin substitute is ...... ntrolled dose escalation trial
@en
P2093
Allen R Comer
April Wicks
B Lynn Allen-Hoffmann
Daniel M Caruso
Jacquelyn A Hank
Joely A Straseski
John M Centanni
Kevin N Foster
Lee D Faucher
Mary A Lokuta
P2860
P304
P356
10.1097/SLA.0B013E318210F3BD
P407
P577
2011-04-01T00:00:00Z